Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ -- Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese domestic player in the high-growth transcatheter

Related Keywords

China ,Suzhou ,Jiangsu ,Peijia ,Henan ,Chinese ,John Kilcoyne ,Michael Zhang ,Peijia Medical Limited ,Jenavalve Technology Inc ,National Medical Products Administration ,Aortic Valve Replacement ,Valve System ,Aortic Regurgitation ,Jenavalve Technology ,Greater China ,Chief Executive Officer ,Late Breaking Clinical Trial ,Cardiovascular Therapeutics ,Annual Scientific Symposium ,